关注
Bruce E. Sands
Bruce E. Sands
在 mssm.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Infliximab for induction and maintenance therapy for ulcerative colitis
P Rutgeerts, WJ Sandborn, BG Feagan, W Reinisch, A Olson, J Johanns, ...
New England Journal of Medicine 353 (23), 2462-2476, 2005
46962005
Infliximab for the treatment of fistulas in patients with Crohn's disease
DH Present, P Rutgeerts, S Targan, SB Hanauer, L Mayer, ...
New England Journal of Medicine 340 (18), 1398-1405, 1999
34501999
Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment
XC Morgan, TL Tickle, H Sokol, D Gevers, KL Devaney, DV Ward, ...
Genome biology 13, 1-18, 2012
28712012
Infliximab maintenance therapy for fistulizing Crohn's disease
BE Sands, FH Anderson, CN Bernstein, WY Chey, BG Feagan, ...
New England Journal of Medicine 350 (9), 876-885, 2004
27472004
Vedolizumab as induction and maintenance therapy for ulcerative colitis
BG Feagan, P Rutgeerts, BE Sands, S Hanauer, JF Colombel, ...
New England Journal of Medicine 369 (8), 699-710, 2013
26402013
Vedolizumab as induction and maintenance therapy for Crohn's disease
WJ Sandborn, BG Feagan, P Rutgeerts, S Hanauer, JF Colombel, ...
New England Journal of Medicine 369 (8), 711-721, 2013
23422013
Selecting therapeutic targets in inflammatory bowel disease (STRIDE): determining therapeutic goals for treat-to-target
L Peyrin-Biroulet, W Sandborn, BE Sands, W Reinisch, W Bemelman, ...
Official journal of the American College of Gastroenterology| ACG 110 (9 …, 2015
18272015
Ustekinumab as induction and maintenance therapy for Crohn’s disease
BG Feagan, WJ Sandborn, C Gasink, D Jacobstein, Y Lang, JR Friedman, ...
New England journal of medicine 375 (20), 1946-1960, 2016
17572016
Tofacitinib as induction and maintenance therapy for ulcerative colitis
WJ Sandborn, C Su, BE Sands, GR D’Haens, S Vermeire, S Schreiber, ...
New England Journal of Medicine 376 (18), 1723-1736, 2017
16882017
Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial
W Hueber, BE Sands, S Lewitzky, M Vandemeulebroecke, W Reinisch, ...
Gut 61 (12), 1693-1700, 2012
15532012
STRIDE-II: an update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD …
D Turner, A Ricciuto, A Lewis, F D’amico, J Dhaliwal, AM Griffiths, ...
Gastroenterology 160 (5), 1570-1583, 2021
13882021
ACG clinical guideline: management of Crohn's disease in adults
GR Lichtenstein, EV Loftus, KL Isaacs, MD Regueiro, LB Gerson, ...
Official journal of the American College of Gastroenterology| ACG 113 (4 …, 2018
12752018
Management of Crohn's disease in adults
GR Lichtenstein, SB Hanauer, WJ Sandborn, ...
Official journal of the American College of Gastroenterology| ACG 104 (2 …, 2009
12532009
Ustekinumab induction and maintenance therapy in refractory Crohn's disease
WJ Sandborn, C Gasink, LL Gao, MA Blank, J Johanns, C Guzzo, ...
New England Journal of Medicine 367 (16), 1519-1528, 2012
12302012
Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis
JF Colombel, P Rutgeerts, W Reinisch, D Esser, Y Wang, Y Lang, ...
Gastroenterology 141 (4), 1194-1201, 2011
10222011
Ustekinumab as induction and maintenance therapy for ulcerative colitis
BE Sands, WJ Sandborn, R Panaccione, CD O’Brien, H Zhang, J Johanns, ...
New England Journal of Medicine 381 (13), 1201-1214, 2019
9752019
The safety of vedolizumab for ulcerative colitis and Crohn's disease
JF Colombel, BE Sands, P Rutgeerts, W Sandborn, S Danese, G D'Haens, ...
Gut 66 (5), 839-851, 2017
8322017
Effects of vedolizumab induction therapy for patients with Crohn’s disease in whom tumor necrosis factor antagonist treatment failed
BE Sands, BG Feagan, P Rutgeerts, JF Colombel, WJ Sandborn, R Sy, ...
Gastroenterology 147 (3), 618-627. e3, 2014
7912014
Infliximab maintenance treatment reduces hospitalizations, surgeries, and procedures in fistulizing Crohn’s disease
GR Lichtenstein, S Yan, M Bala, M Blank, BE Sands
Gastroenterology 128 (4), 862-869, 2005
7262005
Development of the Crohn's disease digestive damage score, the Lémann score
B Pariente, J Cosnes, S Danese, WJ Sandborn, M Lewin, JG Fletcher, ...
Inflammatory bowel diseases 17 (6), 1415-1422, 2011
7072011
系统目前无法执行此操作,请稍后再试。
文章 1–20